Trieu Vuong
Insider CIK 1587074 · MRNA Executive Chairman, Director, 10% owner · SRNE CSO, Director · OTLC Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-10-29 | 2026-10-30 | 1,044,990 | $0.02 | $17.8K | 95,481,309 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-10-28 | 2026-10-30 | 312,000 | $0.02 | $5.8K | 94,436,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2026-07-10 | 2026-07-14 | 2,000 | — | $0 | 2,000 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-07-01 | 2026-07-02 | 240,000 | $0.04 | $9.6K | 94,124,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-06-24 | 2026-06-24 | 115,000 | $0.05 | $5.8K | 93,884,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-06-23 | 2026-06-24 | 75,000 | $0.05 | $3.8K | 93,769,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-06-22 | 2026-06-24 | 65,000 | $0.05 | $3.3K | 93,694,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-06-17 | 2026-06-17 | 239,759 | $0.04 | $9.6K | 93,629,319 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2026-06-15 | 2026-06-17 | 96,000 | $0.05 | $4.8K | 93,389,560 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2026-01-22 | 2026-01-26 | 4,426 | — | $0 | 8,491 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2025-11-17 | 2025-11-19 | 4,065 | — | $0 | 4,065 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-07-10 | 2025-07-10 | 104,000 | $0.01 | $1.0K | 93,293,560 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-07-09 | 2025-07-10 | 1 | $0.01 | $0 | 93,293,561 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-07-08 | 2025-07-10 | 94,736 | $0.01 | $947 | 93,388,297 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-01-31 | 2025-01-31 | 63,775 | $0.03 | $1.9K | 93,189,560 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-01-30 | 2025-01-31 | 100,003 | $0.03 | $3.0K | 93,125,785 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2025-01-29 | 2025-01-31 | 183,066 | $0.03 | $5.5K | 93,025,782 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2024-11-22 | 2024-11-26 | 298,499 | $0.03 | $9.0K | 92,842,716 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2024-08-23 | 2024-08-27 | 500,000 | $0.02 | $10.0K | 92,544,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-06-29 | 2023-06-30 | 425,000 | $0.02 | $8.5K | 92,044,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-06-28 | 2023-06-30 | 75,000 | $0.03 | $2.3K | 91,619,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-06-16 | 2023-06-20 | 100,000 | $0.03 | $3.0K | 91,544,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-06-14 | 2023-06-16 | 400,000 | $0.03 | $12.0K | 91,444,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-05-26 | 2023-05-31 | 126,888 | $0.03 | $3.8K | 91,044,217 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2023-05-02 | 2023-05-02 | 100,000 | $0.05 | $5.0K | 90,917,329 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2022-12-06 | 2022-12-07 | 120,000 | $0.05 | $6.0K | 90,558,021 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2022-11-22 | 2022-11-25 | 70,000 | $0.08 | $5.6K | 90,438,021 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2022-09-26 | 2022-09-28 | 20,000 | $0.07 | $1.4K | 90,368,021 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | P Buy | 2022-08-25 | 2022-08-29 | 80,000 | $0.08 | $6.4K | 90,348,021 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2021-09-03 | 2021-09-08 | 225,000 | — | $0 | 225,000 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award deriv | 2021-07-08 | 2021-07-16 | 513,953 | — | $0 | 513,953 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | A Award | 2021-07-08 | 2021-07-16 | 259,302 | — | $0 | 90,527,323 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion deriv | 2021-03-31 | 2021-07-16 | 74,456 | — | $0 | 0 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion deriv | 2021-03-31 | 2021-07-16 | 13,849 | — | $0 | 0 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion deriv | 2021-03-31 | 2021-07-16 | 5,672 | — | $0 | 0 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion | 2021-03-31 | 2021-07-16 | 5,672,025 | — | $0 | 6,872,529 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion | 2021-03-31 | 2021-07-16 | 13,849,161 | — | $0 | 16,780,384 | SEC↗ |
| OTLC Oncotelic Therapeutics, In | C Conversion | 2021-03-31 | 2021-07-16 | 74,455,719 | — | $0 | 90,268,021 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | P Buy | 2020-11-19 | 2020-11-23 | 50,500 | $0.19 | $9.6K | 15,812,308 | SEC↗ |
| MATN MATEON THERAPEUTICS INC | P Buy | 2020-03-26 | 2020-03-27 | 3,000 | $0.12 | $360 | 15,761,808 | SEC↗ |
| MRNA Marina Biotech, Inc. | D To issuer | 2018-10-01 | 2018-10-04 | 500,000 | $0.50 | $250.0K | 612,716 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award deriv | 2018-04-16 | 2018-04-18 | 2 | $5000.00 | $11.3K | 2 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award deriv | 2018-04-16 | 2018-04-18 | 16,875 | — | $0 | 16,875 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 35 | $5000.00 | $172.6K | 35 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 115 | — | $0 | 115 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 859,725 | $5000.00 | $4.30B | 859,725 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 19 | — | $0 | 19 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 142,500 | — | $0 | 142,500 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 163 | $5000.00 | $813.0K | 163 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 2,564,465 | — | $0 | 2,564,465 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 0 | — | $0 | 0 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy deriv | 2018-04-16 | 2018-04-18 | 0 | $5000.00 | $0 | 0 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy deriv | 2018-04-16 | 2018-04-18 | 0 | — | $0 | 0 | SEC↗ |
| MRNA Marina Biotech, Inc. | C Conversion deriv | 2018-04-16 | 2018-04-18 | 258,825 | — | $0 | 258,825 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award deriv | 2018-01-03 | 2018-01-03 | 3,800 | — | $0 | 3,800 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 0 | $165634.00 | $0 | 473,240 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy | 2017-06-09 | 2017-06-12 | 10,000 | $0.39 | $3.9K | 11,127,141 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy | 2017-06-08 | 2017-06-08 | 20,000 | $0.39 | $7.8K | 11,117,141 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy | 2017-06-07 | 2017-06-08 | 2,500 | $0.38 | $950 | 11,097,141 | SEC↗ |
| MRNA Marina Biotech, Inc. | P Buy | 2017-02-06 | 2017-02-08 | 862,068 | $0.29 | $250.0K | 862,068 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award deriv | 2017-01-03 | 2017-01-04 | 81,000 | — | $0 | 81,000 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award | 2016-11-15 | 2016-11-22 | 5,255,354 | — | $0 | 5,255,354 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award | 2016-11-15 | 2016-11-22 | 23,123,558 | — | $0 | 23,123,558 | SEC↗ |
| MRNA Marina Biotech, Inc. | A Award | 2016-11-15 | 2016-11-22 | 11,094,641 | — | $0 | 11,094,641 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 36,000 | — | $0 | 36,000 | SEC↗ |